|
CAUTION …This Timeline is based Solely on Facts and History
What ever conclusions you come to, are strictly your own. |
1578
The 1st
recognized
description of
Whooping cough
by Dr.
Guilluame
Bailou in
France. The
lung is so
irritated
that, in its
attempts by
every effort
to cast forth
the cause of
the trouble,
it can neither
admit breath
nor easily
give it forth
again. The
sick person
seems to swell
up as it is
about to
strangle,
holds it
breath
coughing
sometimes for
space of 4 or
5 hours, than
the paroxysm
of coughing
returns, …it
was resistance
to every
medicine. The
cough was very
fatiguing,
upset the
stomach and
caused
vomiting; or
it shattered
the veins of
the brain,
causing blood
to spurt forth
in
hemorrhages.
These stopped
for several
days, but in
July and
August they
returned, more
violent than
ever and
attached
children
primarily.
1694
Queen Mary II
of England
dies of small
pox. More than
60 million
people in
Europe would
die from small
pox during the
next decade.
1721
Boston,
Zabdiel
inoculated his
only son with
small pox and
was mobbed by
angry citizens
denouncing his
action.
1796
Edward Jenner,
British
physician
noted that
dairy maids
who had caught
“cowpow” (a
minor disease)
could not
catch small
pox (a major
disease).
1798
Edward Jenner
introduced the
practice of
vaccinations
by inoculating
a boy with
cowpox pus and
demonstrating
that, when
subsequently
inoculating
with smallpox
pus, he did
not come down
with the
disease.
1853
England passes
a compulsory
vaccine law
for smallpox.
1904
A Supreme
Court decision
removed
individual
rights to
refuse vaccine
immunizations.
1912
The 1st
whooping cough
vaccine was
created by
French
bacterists
Jules Bordet &
Octave Gengou.
1915 – 1958
Greater than a
95% decline in
measles was
documented,
long before
the measles
vaccine was
introduced.
1923-1925
Danish
researcher,
Thorvaid tried
out a modified
pertussis
vaccine during
a whooping
cough epidemic
in the Faroe
Islands. He
vaccinated
babies and
while it did
not prevent
whooping
cough, it
appeared to
make the
disease milder
and reduced
the number of
deaths.
1930’s –
1940’s
Scientist and
Doctor’s try
to defend the
best possible
way to make
the vaccine
and keep it
safe along
with the best
age for
administrating
the 1st shot
and whether to
combine it.
1933
The 1st death
associated
with the
pertussis
vaccine was
documented by
Thorvaid
Madsen in
Copenhagen.
1936
Pertussis
becomes
available in
the United
States.
1938
Baltimore,
Maryland – a 5
year old boy
was brought to
the John
Hopkins
University to
see child
psychiatrist,
Leo Kanner.
Late 1930’s
American
researchers
reported that
some children
reacted with
fevers,
convulsions
and collapse.
But, most
Doctor’s
discounted
those reports
convinced that
reactions were
insignificant
compared to
the protection
that vaccine
gave them
against
whooping
cough.
1940
Pertussis is
put into
general use in
the United
States.
1941
Louis Sauer
developed his
own pertussis
vaccine and
urged that
pertussis
vaccines begin
no earlier
than 7 months
of age.
1942
Louis A. Lurie
MD and Soy
Levy MD
reported at an
AMA that
whooping
cough, which
had long been
recognized as
a cause of
brain damage,
may also
through a less
dramatic but
equally
serious injury
to the brain,
causing a wide
variety of
behavior
disturbances.
There appears
to be a
definite
relationship
between the
neurological
sequence of
the whooping
cough and the
behavior
disorders and
personality
changes shown
…in later
life.
1943
Alum or
alum-based
substances
were added to
the vaccine.
1945
First autistic
child reported
in Japan.
1946
Kendrick and
Pittman hit
upon the idea
of challenging
or exposing
vaccinated
mice to
whooping cough
by injecting
the
challenging
doses of
pertussis
bacteria
directly into
their brains.
The vaccine’s
ability to
protect
against
whooping cough
(potency or
efficacy) was
judged by how
many mice
survived and
how many died
after being
infected with
the disease.
Were & Garrow
described the
deaths of
identical
twins who died
within 24
hours of their
2nd shot.
Douglas
Buchanan MD, a
professor of
neurology at
the University
Of Chicago
School Of
Medicine,
called
attention to a
neurological
disorder which
he believed
was often
misdiagnosed.
He wrote, "a
type of major
convulsions in
young infants
which is
frequently not
recognized as
such is one in
which there is
a sudden
forward
dropping of
the head with
adduction and
flexion of the
arms. These
attacks are
extremely
brief and tend
to occur in
bursts. They
are really
“lightening
major
convulsions”.
They are more
common in
children less
than 2 years
old. They are
notoriously
difficult
completely to
control and
are most often
found in
association
with severe
degrees of
cerebral
agencies and
mental
retardation.”
Late 1940’s
Government,
Health
Officials and
Physicians
were
aggressively
promoting
pertussis
vaccination
throughout
America as the
incidence of
whooping cough
was highly
declining.
1948
A correlation
between diet
and polio is
discovered.
The Prevention
Vaccine Law of
1948 was
enacted making
it a legal
requirement
for children
to be
inoculated in
Japan. It was
adopted by the
order of the
American
Occupational
Army.
Vaccinations
were to begin
at 3 months.
Randolph K.
Byers &
Fredick C.
Moll of
Harvard
Medical School
published an
article
describing
children who
had suffered
brain damage
after
receiving the
pertussis
vaccine. Their
findings
shocked the
medical
community and
provide clear
substantiation
that the
vaccine caused
serious
neurological
complications
in children.
Louis Sauer
made an
observation
after Toomey
presented his
report in 1949
(Beyer and
Moll study)
pointing out
that
neurological
damage caused
by vaccine
resembles the
damage caused
by whooping
cough.
1949
The Division
of Biologics
Standards
(DBS) of the
Public Health
Service
established a
national
potency test
and modified
it in 1953 to
establish
maximum &
minimum policy
limits.
1950’s
Europe
received the
pertussis
vaccine.
Pertussis is
in full swing
in the United
States
The National
Institute of
Health was
well aware
that the Salk
vaccine was
ineffective
and deadly.
Salk was
quoted as
saying, “when
you inoculate
your child,
you don’t
sleep well for
2 to 3 weeks.”
1953
S. Kong MD, of
the pediatric
clinic of the
University of
Zurich,
compiled a
list of 82
cases.
Polio death
rate in the
United States
and England
decreased by
47-55%. Stats
declined in
Europe as
well.
1954
Miller and
Straton
described the
case of a baby
girl who
reacted to her
3rd DPT shot.
“Seven days
after her 3rd
injection on a
combined
diphtheria-pertussis
vaccine, this
previously
healthy baby
developed a
severe attack
of screaming
followed by
drowsiness.
During the
subsequent 2
days the child
remained
alternately
drowsy and
restless,
though she was
able to take
her food. At
the end of
this period
the parents
noticed that
she was not
moving her
right arm and
leg.
Examination
revealed a
right
hemiplegia
involving
face, arm and
leg. Two years
later, right
hemiparesis
persists.
There is
difficulty in
using the
right hand,
but the child
can walk.
General
development
and
intelligence
appears to be
unimpaired.
1954 – 1965
The
manufactured
vaccine is
subject to the
toxicity test
developed and
refined by
Pittman and
others at the
DBS. This test
is supposed to
measure the
vaccines
safety,
meaning how
likely is it
to cause
severe
reactions in
children? This
was plagued
with problems.
When Pittman
tried to
redefine it in
the late
1950’s, some
mice seemed to
gain weight
over a period
of time. If
the mice do
not die and
continue to
gain a
specific
amount of
weight,
vaccine
manufacturers
and the FDA
consider the
vaccine safe
for children.
1955
Neils Loos of
the Department
of Neurology,
University of
Illinois
School of
Medicine
showed that
the EEG of
infants
sometimes was
altered by the
DPT shot. He
concluded
that, “mild,
but possibly
significant,
cerebral
reactions
occur in
addition to
the reported
very severe
neurological
changes.” In
spite of these
warnings,
Doctor’s
continued to
insist that
the small
damage caused
by the
pertussis
vaccine was
offset by the
lack of
serious
reactions in
the hundreds
of thousands
of infants who
were regularly
vaccinated.
But upon what
evidence did
they base this
assumption?
Dr. Jonas Salk,
American
Physician &
Microbiologist
developed a
“killed virus”
against Polio.
Albert Sabin
also an
American
Physician and
Microbiologist
developed a
“live-viral”
(oral) vaccine
against polio.
Natural polio
virus produces
no symptoms at
all in 90% of
the people
exposed to it,
even under
epidemic
conditions.
1957
William Landau
and Frank
Kleffner
discover the
1st case of
Landau-Kleffner
Syndrome.
Parke-Davis
decided to
combine the
new Salk polio
vaccine with
the existing
DPT vaccine,
Triogen. The
new product
called
Quadrigen, was
licensed by
the Government
in July of
1959. When it
was withdrawn
from
circulation
from the
market 9 years
later, more
than 8 million
doses had been
injected into
nearly 3
million
babies.
Late 50’s
Pertussis is
promoted on a
large scale in
England.
1960
The
Massachusetts
Department of
Public Health
found that
Quadrigen was
not passing
the states
potency tests.
The company’s
response was
to abruptly
increase the
number of
pertusis
bacteria per
unit of the
vaccine. This
was an almost
incomprehensible
step, since it
meant changing
the
composition of
the vaccine
after the
license had
already been
issued.
1961
J.M.H. Hooper,
a senior
medical
officer in
Northern
England, found
that some
parents were
refusing to
bring their
children into
local health
clinics for
further DPT
shots. He
investigated
and found the
reason to be
occasional
violent
reactions to a
previous shot.
No one paid
attention to
this.
1963
A team of
Scientist’s
headed by John
F. Enders
created a
measles
vaccine. Mass
inoculation
would soon
follow.
1964
The Cude vs.
Arkansas case
reinforced the
1904 United
States Supreme
Court decision
that States
have the right
to enforce
mandatory
vaccination
laws.
1965
Margaret
Pitman, the US
leading
pertussis
vaccine expert
states,
Bordetella
pertussis is
unique among
infectious
bacteria in
its marked
ability to
modify
biological
responses.
Therefore,
there has been
special
concern that
pertussis
vaccine is as
free as
possible from
reactive
factors and
yet provides
adequate
protection
against
whooping
cough.
The United
States
Congress
passed the
Immunization
Assistance Act
setting up
categorical
grant program
to States and
large
Metropolitan
areas to
establish
immunization
programs.
Mid 1960’s
Many States
had laws
requiring DPT
and Polio
vaccinations,
most of them
ensuring
compliance by
making the
vaccination
requirement
mandatory for
entry into
elementary
school.
1967
Strom wrote
that his
earlier
article on
averse
reactions had
aroused,
“considerable
attention and
also
criticism,”
but insisted
that the
convulsions ,
shock and
abnormal
irritability
observed after
the triple
vaccination
cannot always
be regarded as
common place
general
symptoms but
rather reflect
an objectively
demonstrable
cameral
reaction. The
vaccination
reactions may
be regarded
chiefly as
manifestations
of a toxic
effect, an
individual
predisposition
being of some
significance.
1968
Quadrigen was
withdrawn from
the market due
to the fact it
was highly
reactive in
small
children.
1969
Dr. Charlotte
Hannik found a
history of
allergies in
20 of the 35
children who
reacted with
persistent
screaming,
shock/collapse,
or convulsions
to the
DPT-Pertussis
vaccinations.
1970
A vaccine
against
Hepatitis was
developed and
made
available.
1971
MRI (tri-valent
measles/mumps/rubella)
vaccine is
licensed.
1972
Ribcoff Senate
hearings – the
DBS was
transferred
from the
Public Health
Service (PHS)
to the Food
and Drug
Administration
where it
became the
Bureau of
Biologics (B)B)
headed by
Harry Meyer.
USA ends the
practice of
routine
smallpox
vaccine.
1974
Estimated in
Britain were
80 cases of
severe
neurological
complications
annually; 1/3
of these
children died,
and 1/3 were
left with
residual brain
damage. They
admitted to
being, “not
entirely
convinced that
the community
benefits from
whooping cough
and
vaccination
outweighs the
damage it may
be doing.”
1975
Japan pulls the Pertussis
off the market
following
publicity
about two
Pertussis
related
vaccine
deaths. Japan
comes back
later that
year and
introduces
another
vaccine, one
that is less
toxic. This
time
inoculation
will not begin
until the age
of two.
World Health
Organization
(WHO)
sponsored an
International
meeting on
Pertussis
vaccine
experts. They
recommended
that “children
from families
with a history
of
neurological
disorders
should not be
vaccinated.”
Vaccine lot
#1182 was sent
to the FDA for
routine
testing prior
to release.
The FDA found
that lot #1182
was three
times more
potent than
the
regulations
allowed and
refused to
allow the
State of
Michigan to
distribute it
outside the
State. Rather
than
immediately
destroy the
infective lot,
which
represented
about 400,000
doses,
Michigan
health
officials
decided to see
just how
reactive it
was by testing
it on several
hundred
children in
Ingham County.
To date, court
records show
that at least
three children
injected with
vaccine from
lot #1182
suffered
reactions
which left
them with
seizures,
paralysis and
brain damage.
The parents
sued the
Michigan
Department of
Public Health,
describing the
Department’s
use of the
vaccine as
“potentially
lethal
misconduct and
showing
callous
disregard for
human life.”
The flu
vaccine is
made
available;
more than 500
people were
paralyzed with
Guillian Bare
Syndrome.
Dr. Jonas Salk
testified that
the live-virus
vaccine (used
almost
exclusively in
the United
States since
the 1960’s was
the “principal
cause, if not
sole cause of
all reported
cases of polio
in the United
States.”
Charles
Manclark, FDA
Pertussis
specialist
states,
“Pertussis
vaccine is one
of the more
troublesome
products to
produce and
assay. As an
example of
this,
Pertussis
vaccine has
one of the
highest
failure rates
of all
products
submitted to
the Bureau of
Biologitics
for testing
and release.
Approximately
15 to 20
percent of all
lots which
pass the
manufacturer’s
tests fail to
pass the
Bureau’s
test.”
1976
West Germany
ends its mass
pertussis
immunization
program.
1997
Gordon T.
Stewart MD, of
the Department
of Community
Medicine,
University of
Glasgow in
Scotland,
published a
study
analyzing 160
cases of
adverse
reactions and
neurotoxicity
following DPT
vaccinations.
He reported
that in 65
children,
reactions were
“followed by
convulsions,
hyperkinesias
(hyperactivity)
and severe
mental
defect.” He
concluded, “It
seems likely
that most
adverse
reactions are
unreported and
that may be
overlooked.”
Austria and
Southern
German
introduced a
new oral
vaccine by
Behring
Laboratories
in Vienna.
This is given
to new borns
while they are
still in the
hospital. It
is inserted
into their
nasal
passages. To
date there
have been no
reported side
effects.
1978
Griffith
studied severe
reactions
occurring
after 15
million doses
of the
pertussis
vaccine were
administered
to children in
England. He
stated that
one child “was
admitted to
the hospital
with prexia
signs and
symptoms of
meningeal
irritation,
transferred
after three
days with
provisional
diagnosis of
encephalomyelitis
, but died 30
days after
vaccination;
necropsy
showed no
specific
changes.
Recorded cause
of death was
encephalopath
due to
injection of
the triple
vaccine.”
1979
Rubella
vaccine was
introduced.
The Swedish
Government
withdrew
support from
the pertussis
vaccine
because
authorities
were beginning
to doubt it’s
effectiveness
in controlling
whooping cough
and were
worried about
a large number
of serious
reactions. The
vaccine had
been changed
and the
toxicity had
been altered.
Thereafter,
the incidence
of whooping
cough rose
almost to
revaccination
levels.
The United
States Food
and Drug
Administration
funded a study
representing
the 1st large
scale attempt
in the United
States
government to
evaluate
reactions to
the DPT shot.
The study
conducted at
the University
of California
in Los
Angeles, was
co-authored by
Cody Baraff,
Cherry Marcy
and FDA
pertussis
vaccine
researcher,
Charles
Manclark Ph.D.
and published
in Pediatrics
in 1981.
California
Physicians,
Jack Jacok and
Frank Manning
wrote in the
American
Journal of the
Diseases of
children about
the case of a
child who
experienced a
“building
fontanel
associated
with increases
intra cranial
pressure as
measured by
the lumbar
puncture,”
within 24
hours of the
DPT shot. This
7 month old
girl who was
the daughter
of an
Pediatrician,
began running
a high fever
after her
third DPT shot
and nine hours
later, her
parents
noticed the
soft spot on
her head was
bulging and
pulsating. He
became
irritable and
also had
redness and
swelling on
the site
injection. She
was admitted
to the
hospital and
although the
tests came
back negative,
the bulging
did not stop
until after 40
hours after
the shot. The
Doctor’s
concluded,
“The clinical
symptom logy
in this
patient,
consisting of
fever and
irritability
are symptoms
frequently
associated
with DPT
immunization.
The bulging
fontanel was
accidentally
noted by the
child’s
parents who
recognized its
importance. It
is therefore,
conceivable
that this
complication
may be missed
unless
specifically
looked for.”
Barkin and
Pichichero in
Colorado
reported a
very high
proportion of
unusual
symptoms. In
their study,
only seven
percent of the
parents
reported no
reactions.
Twenty seven
percent
reported mild
reactions and
fifty nine
percent
reported
moderate
reactions
while seven
percent
reported
severe
reactions.
1980
West German
Physician
Wolfgang
Ehrengut
suggested in
one of his
studies that
Doctor’s have
a negative
bias against
vaccine
reactions, and
UN willingness
to believe,
because “what
must be not
true,
therefore,
cannot be.” It
must be true,
for whatever
will they do
if it is not?
1981
“Acelluer
Pertussis -
DTaP,”
(Japanese
pertussis) is
a new vaccine
in introduced
in Japan. They
claim it is
less toxic and
more
effective.
D.L. Miller
MD, and others
published and
analysis of
the 1st one
thousand cases
of
neurological
illness
reported to
the health
officials
conducting the
NCES. Thirty
five of these
cases had
received the
pertussis
vaccine within
seven days of
becoming ill.
The author’s
concluded, “A
significant
association
was shown
between
serious
neurological
illness and
pertussis
vaccine.”
The British
National
Childhood
Encephalopath
Study (NCES),
found a
statistical
correlation
between the
DPT shot and
neurological
illness
occurring
within seven
days of the
shot.
1982
FDA Symposium,
a Japanese
scientist
pointed out
that the toxic
substances
produced by
the “B
pertussis,”
may not be
responsible
for the
neurological
complications
of whooping
cough, as well
as those of
the vaccine
which contains
the ’B’
pertussis.”
The television
broadcast in
the United
States: “DPT;
Vaccine
Roulette,” the
microbiologists
Bobby Young
said, “If a
child is not
frankly
rendered a
vegetable,
…how many
infants that
are receiving
this are in
some way
damaged by the
vaccine, and
how can you
proved they
haven’t been,
or they have
been? All of
them have been
vaccinated.”
Young was
critized by
physicians in
positions of
leadership in
the American
medical
establishment
and the FDA
for making
these
statements.
“The number of
well children
who have
suffered
mental or
physical
disturbance as
a result of
vaccination
may have to be
counted not in
the hundreds,
as in the
United States
or in
thousands all
over the
world. This is
a heavy price
to pay for a
disease that
seldom
nowadays
threatens the
life or health
of our
children.”
Shortly after
that broadcast
aired, a group
of parents
band together
and form
Dissatisfied
Parents
Together (DPT)/
Their goal is
to gather
vaccine
information
about the
pertussis, get
information
out to parents
and find ways
to lesson
pertussis
vaccine
damage.
1983
Larry Baraff
MD, who was
the principal
author of the
UCLA-FDA study
published in
the USA in
1979 and
August of 1980
said fifty
three percent
of children
who received a
DPT
immunization,
six died
within twenty
four hours and
eleven more
died seven
days of the
DPT shot.
Senator Paul
Hawkins (R-FL)
introduced the
National Child
Vaccine Injury
Act (S-2117)
in November.
Lawrence
Steinman MD,
Stanford
University and
London
Hospital
published a
study in
Nature
suggesting
that some
children with
allergies may
be genetically
predisposed to
reacting to
the pertussis
vaccine. The
susceptibility
to the “B”
pertussis
immunization
in humans may
be controlled
by genes. The
possibility
that adverse
reactions to
routine
immunization
may be under
genetic seems
novel. There
is clearly a
connection
between
allergies,
especially
milk allergies
and the
tendency to
react severely
to pertussis
vaccines. The
vaccine
interacts with
the mechanisms
in the body
that are
involved in
allergy and
hypersensitivity.
1984
Merck Sharp
and Dohme
announced the
creation of a
chicken pox
vaccine that
it hopes to
make available
to the
American
public in
several years.
However,
concern about
the
possibility
that the
vaccine might
have side
effects
including Rye
Syndrome, an
occasional
complication
of chicken pox
disease and
influenza, as
well as
delayed
effects that
do not appear
for years, has
been expressed
by several
observers.
1985
The HIB (Hemophilus
influenza B)
is taken off
the market due
to safety and
efficacy
reasons.
1986
The passage of
the National
Vaccine Injury
Act of 1986.
All physicians
administrating
vaccines are
now required
by law to
inform parents
about the
possible
dangers
from an
adverse
reaction
before giving
the DPT shot.
In addition,
in order to
recognize a
babies
symptoms, the
mother can
always ask a
Doctor to
provide a copy
of the
manufacturer’s
product
information
sheet included
in every
package of the
vaccine as
well as
verbally
explain in
grater detail
the symptoms
of the severe
reactions,
such as
convulsions,
collapse, high
fever and the
steps one
should be
taken if these
symptoms are
observed.
Vaccine
Adverse
Reporting
System (VAERS)
was set up for
Doctor’s to
report adverse
reactions to
vaccines.
Monitoring
System for
Adverse Events
Following
Immunizations
(MASEF) was
set up for
public health
clinic
Doctor’s to
report adverse
reactions.
1987
HIB vaccine is
licensed.
1988
The
information
insert placed
in packages of
DPT vaccine
manufactured
by Lederle
Laboratories
stated:
“pertussis
vaccine has
been
associated
with a greater
proportion of
adverse
reactions than
many other
childhood
diseases.”
The Vaccine
Injury
Compensation
Act is funded.
The HIB
vaccine is
added to the
schedule for
infants and
children.
1989
International
Workshop on
Neurological
Complications
of Whooping
Cough and
Pertussis
Vaccine led by
John Menkes
MD, Professor
Emergency of
Neurology and
Pediatrics at
UCLA. The
consensus of
scientists
attending was
that, “there
is sufficient
data to
implicate both
endotoxin and
pertussis in
neurological
complications
of the disease
and in adverse
reactions to
the pertussis
vaccine.”
Italian
parents refuse
to allow the
whole cell
vaccine to be
used on their
children due
to reported
side effects.
AAP and ACIP
along with
Lederle stated
that
convulsions
occurring
within three
days of a DPT
shot were a
contradiction
to further
pertussis
vaccine,
although
Connaught
listed seven
days. However,
there are
cases in the
scientific
literature
linking
convulsions
occurring up
to two weeks
after the DPT
shots to the
pertussis
vaccine.
CDC stated
that, “that
the chance of
a child having
a convulsion
with fever
after
receiving a
DPT vaccine is
up to nine
times greater
if a child had
a convulsion
before.”
1990
United States
Claims Court
revealed that
ninety two
cases of
vaccine injury
and death
had been
decided under
the National
Vaccine Injury
Act of 1986.
More than half
the awards
were made to
parents whose
children had
died following
DPT vaccine
reactions.
Most of the
children’s
death
certificates
listed cause
of death as
sudden infant
death (SIDS).
The conjugate
HIB vaccine is
licensed.
1991
Conjugated HIB
was
recommended
and made
available for
use in infants
as young as
two months.
1992
The AAP
recommended
the acelular
pertussis
vaccine for
the 4th or 5th
doses only.
1993
The DPTH (DPT-Hib
combo) vaccine
was licensed.
1995
Iceland is the
ONLY Western
Europe country
to require
pertussis
immunization.
Varicella
Vaccine
licensed.
1996
Dtap licensed;
recommended
for use
instead of
whole-cell DPT
Hib-HepB combo
vaccine is
licensed
1998
Lyme vaccine (Lymerix)
is licensed
Rotavirus
vaccine is
recommended by
CDC for
universal use
in infants.
Rotavirus
vaccine is
licensed.
1999
Rotavirus
vaccine pulled
off the market
due to
significant
adverse
reactions
1999/2000
A Joint
Statement by
the U.S.
Public Health
Service, the
AAFP, the AAP,
and ACIP
urging
manufacturers
to remove the
preservative
thimerosal as
soon as
possible from
vaccines
routinely
recommended
for infants.
2000
Prevnar (pneumococcal
conjugate
vaccine)
licensed.
CDC recommends
use of IPV
instead of OPV
(polio
vaccine).
2002
GSK pulled
Lymerix off
the market.
Pediarix (penta-valent
DtaP/HepB/IPV)
licensed.
CDC encourages
flu vaccine
for children.
2003
Inhaled flu
vaccine (Flumist)
being reviewed
for approval
by the FDA.
Smallpox
vaccine for
first-responders.

The Centers
for Disease
Control (CDC)
and the FDA
are supposed
to work
together to
protect the
public health
and safety by
monitoring
vaccine
reactions.
The FDA tests
vaccines for
potency and
toxicity,
while the CDC
surveys the
incidence of
whooping cough
in the country
and collects
reports on
vaccine
reactions.
A “hot lot”
is defined as
one that
generates at
least two
reports of
illness,
seizures or
death.
Reports are
supposed to
trigger an
investigation
of the vaccine
lot and
withdrawal of
one that
appears to be
especially
toxic.
Lederle Lot
number 585-61,
distributed in
1980, met the
“hot-lot”
criteria but
was NOT
withdrawn from
circulation.
It remained on
the market
until all
vials had been
sold.
AND STILL WE
CONTINUE TO
VACCINATE?
[Reprinted and
Updated from
TALK
Newsletter,
Vol. 5, Issue
5, 1996 with
permission.]

GO TOP
|